London Stock Exchange: TSTL
Tristel Plc designs, develops, manufactures and sells infection control, contamination control and hygiene products. It provides services on infection control products for public and private sector hospitals. The company operates through three segments: Hospital Infection Control, Animal Healthcare and Pharma & Personal Care. The Hospital Infection Control segment is engaged in the manufacture, development and sale of infection control and hygiene products which is grouped as Tristel, a proprietary chlorine dioxide formulation, which are used to disinfect instruments and surfaces and to control legionella and biofilm build up in water. The Animal Healthcare segment offers manufacture of disinfection and cleaning products for sale and distribution to veterinary and animal welfare sectors. The Pharma & Personal Care segment manufactures and distributes disinfectants and detergents and are grouped together under the Crystel brand. The company was founded by Paul C. Swinney in 1993 and is headquartered in Snailwell, United Kingdom.
Lynx Business Park Fordham Road Unit 1B
Snailwell, CA CB8 7NY
SIC Code: 3841